Related Experiment Videos
Bacterial enteric infections and vaccine development
1Department of Medical Microbiology and Immunology, University of Göteborg, Sweden.
Gastroenterology Clinics of North America
|June 1, 1992
Summary
New vaccines targeting major bacterial enteropathogens offer hope for reducing diarrheal diseases globally. These advancements aim to protect both travelers and populations in developing countries from severe enteric infections.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Bacterial enteric infections cause significant global morbidity and mortality, particularly in developing nations and among international travelers.
- Understanding pathogen-host interactions and immune responses is crucial for developing effective vaccines against invasive and non-invasive enteric pathogens.
- Existing challenges include the need for vaccines against common causes of diarrhea, dysentery, and enteric fever.
Purpose of the Study:
- To review the development and efficacy of new vaccines against major bacterial enteropathogens.
- To highlight the role of mucosal and systemic immunity in protection against enteric infections.
- To assess the potential of these vaccines for public health interventions and traveler prophylaxis.
Main Methods:
- Review of pathogenesis studies focusing on ligand-receptor interactions and disease mechanisms.
- Analysis of research on protective immune mechanisms, including secretory IgA and T-cell responses.
- Evaluation of clinical trial data for newly developed cholera, typhoid, ETEC, and Shigella vaccines.
Main Results:
- Several new vaccines, including oral killed cholera vaccines, live attenuated (Ty21a) and injectable Vi typhoid vaccines, have demonstrated efficacy in field trials.
- Early-stage human trials are underway for killed oral ETEC and live attenuated Shigella vaccines.
- These vaccines target key bacterial enteropathogens responsible for significant diarrheal diseases.
Conclusions:
- Newly developed vaccines show promise for controlling bacterial enteric infections in endemic regions.
- These vaccines are expected to be valuable for preventing traveler's diarrhea.
- Continued development and implementation of these vaccines could significantly reduce the global burden of enteric diseases.